- Home
- VERI vs PRTA Comparison
VERI vs PRTA Comparison
Compare VERI & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VERI | PRTA |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 537.1M | 538.3M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | VERI | PRTA |
|---|---|---|
| Price | $3.79 | $9.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $10.00 | ★ $18.86 |
| AVG Volume (30 Days) | ★ 2.2M | 515.7K |
| Earning Date | 03-12-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $98,027,000.00 | $11,786,000.00 |
| Revenue This Year | $20.56 | N/A |
| Revenue Next Year | $19.11 | $1,183.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.74 | N/A |
| 52 Week Low | $1.22 | $4.32 |
| 52 Week High | $9.42 | $16.67 |
Technical Indicators
Market Signals| Indicator | VERI | PRTA |
|---|---|---|
| Relative Strength Index (RSI) | 30.74 | 44.34 |
| Support Level | $3.80 | $8.65 |
| Resistance Level | $4.25 | $10.53 |
| Average True Range (ATR) | 0.22 | 0.44 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 4.47 | 29.52 |
Price Performance
Historical ComparisonAbout VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.